GSA Capital Partners’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
GSA Capital Partners's IRMD Position: Q1 2026 in Review
GSA Capital Partners reduced its iRadimed (IRMD) stake by 35% in Q1 2026, selling an estimated $386K and leaving 7,274 shares worth $700K. The position accounts for 0.04% of the portfolio, ranked #705.
GSA Capital Partners first reported a position in IRMD in Q3 2015 and has held it in 17 quarters since. The position peaked at $1.41M in Q4 2015. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- GSA Capital Partners held 7,274 shares of iRadimed worth $700K as of Q1 2026.
- GSA Capital Partners sold 3,860 iRadimed shares in Q1 2026, an estimated $386K.
- iRadimed made up 0.04% of GSA Capital Partners's portfolio in Q1 2026, its #705 holding.
- GSA Capital Partners first reported a position in iRadimed in Q3 2015 and has held it in 17 quarters since.
- GSA Capital Partners's iRadimed position peaked at $1.41M in Q4 2015.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.